2-107987955-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021815.5(SLC5A7):c.-51-150T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0496 in 435,132 control chromosomes in the GnomAD database, including 775 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.060 ( 358 hom., cov: 33)
Exomes 𝑓: 0.044 ( 417 hom. )
Consequence
SLC5A7
NM_021815.5 intron
NM_021815.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.548
Publications
0 publications found
Genes affected
SLC5A7 (HGNC:14025): (solute carrier family 5 member 7) This gene encodes a sodium ion- and chloride ion-dependent high-affinity transporter that mediates choline uptake for acetylcholine synthesis in cholinergic neurons. The protein transports choline from the extracellular space into presynaptic terminals for synthesis into acetylcholine. Increased choline uptake results from increased density of this protein in synaptosomal plasma membranes in response to depolarization of cholinergic terminals. Dysfunction of cholinergic signaling has been implicated in various disorders including depression, attention-deficit disorder, and schizophrenia. An allelic variant of this gene is associated with autosomal dominant distal hereditary motor neuronopathy type VIIA. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
SLC5A7 Gene-Disease associations (from GenCC):
- neuronopathy, distal hereditary motor, type 7AInheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- congenital myasthenic syndrome 20Inheritance: AR Classification: STRONG Submitted by: G2P, Ambry Genetics, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- distal hereditary motor neuropathy type 7Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- presynaptic congenital myasthenic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-107987955-T-C is Benign according to our data. Variant chr2-107987955-T-C is described in ClinVar as [Benign]. Clinvar id is 1295904.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.108 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0604 AC: 9183AN: 152140Hom.: 358 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
9183
AN:
152140
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0438 AC: 12381AN: 282874Hom.: 417 AF XY: 0.0448 AC XY: 6478AN XY: 144676 show subpopulations
GnomAD4 exome
AF:
AC:
12381
AN:
282874
Hom.:
AF XY:
AC XY:
6478
AN XY:
144676
show subpopulations
African (AFR)
AF:
AC:
953
AN:
9742
American (AMR)
AF:
AC:
413
AN:
11590
Ashkenazi Jewish (ASJ)
AF:
AC:
428
AN:
10008
East Asian (EAS)
AF:
AC:
1165
AN:
25630
South Asian (SAS)
AF:
AC:
1096
AN:
9352
European-Finnish (FIN)
AF:
AC:
1123
AN:
21008
Middle Eastern (MID)
AF:
AC:
47
AN:
1406
European-Non Finnish (NFE)
AF:
AC:
6376
AN:
176066
Other (OTH)
AF:
AC:
780
AN:
18072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
540
1079
1619
2158
2698
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0603 AC: 9182AN: 152258Hom.: 358 Cov.: 33 AF XY: 0.0627 AC XY: 4668AN XY: 74458 show subpopulations
GnomAD4 genome
AF:
AC:
9182
AN:
152258
Hom.:
Cov.:
33
AF XY:
AC XY:
4668
AN XY:
74458
show subpopulations
African (AFR)
AF:
AC:
4103
AN:
41538
American (AMR)
AF:
AC:
790
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
160
AN:
3470
East Asian (EAS)
AF:
AC:
168
AN:
5188
South Asian (SAS)
AF:
AC:
560
AN:
4820
European-Finnish (FIN)
AF:
AC:
557
AN:
10610
Middle Eastern (MID)
AF:
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2621
AN:
68010
Other (OTH)
AF:
AC:
120
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
439
878
1317
1756
2195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
298
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Oct 17, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.